INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 222 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $442,000 | -34.9% | 123,167 | -9.5% | 0.00% | – |
| Q4 2021 | $679,000 | -27.9% | 136,064 | +3.4% | 0.00% | -100.0% |
| Q3 2021 | $942,000 | -34.3% | 131,545 | -14.9% | 0.00% | 0.0% |
| Q2 2021 | $1,433,000 | +13.6% | 154,560 | +13.8% | 0.00% | 0.0% |
| Q1 2021 | $1,261,000 | +27.4% | 135,846 | +21.4% | 0.00% | 0.0% |
| Q4 2020 | $990,000 | -34.0% | 111,878 | -13.5% | 0.00% | 0.0% |
| Q3 2020 | $1,501,000 | -64.1% | 129,354 | -16.6% | 0.00% | -66.7% |
| Q2 2020 | $4,182,000 | +363.1% | 155,190 | +27.8% | 0.00% | +200.0% |
| Q1 2020 | $903,000 | +124.1% | 121,392 | -0.7% | 0.00% | – |
| Q4 2019 | $403,000 | +205.3% | 122,200 | +90.2% | 0.00% | – |
| Q3 2019 | $132,000 | +29.4% | 64,262 | +85.6% | 0.00% | – |
| Q2 2019 | $102,000 | +37.8% | 34,632 | +73.8% | 0.00% | – |
| Q1 2019 | $74,000 | +23.3% | 19,924 | +33.3% | 0.00% | – |
| Q4 2018 | $60,000 | -9.1% | 14,944 | +26.6% | 0.00% | – |
| Q3 2018 | $66,000 | -32.7% | 11,805 | -52.9% | 0.00% | – |
| Q2 2018 | $98,000 | -90.1% | 25,038 | -88.0% | 0.00% | -100.0% |
| Q1 2018 | $986,000 | +6.1% | 209,445 | -6.9% | 0.00% | 0.0% |
| Q4 2017 | $929,000 | -22.5% | 225,005 | +19.1% | 0.00% | 0.0% |
| Q3 2017 | $1,198,000 | +514.4% | 188,908 | +800.9% | 0.00% | – |
| Q3 2016 | $195,000 | -67.4% | 20,969 | -67.7% | 0.00% | -100.0% |
| Q2 2016 | $599,000 | +487.3% | 64,868 | +267.8% | 0.00% | – |
| Q3 2015 | $102,000 | -35.0% | 17,636 | -8.1% | 0.00% | – |
| Q2 2015 | $157,000 | -40.5% | 19,188 | -33.3% | 0.00% | -100.0% |
| Q4 2014 | $264,000 | -10.2% | 28,784 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $294,000 | -2.6% | 29,844 | +6.7% | 0.00% | 0.0% |
| Q2 2014 | $302,000 | – | 27,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |